Table 2. Frequencies of potential D-interactions with risk of toxicity, categorized according to potential clinical effect.
| Potential adverse effect | Frequency |
|---|---|
| Serotonin toxicity and/or anticholinergic side effects | 87 |
| SSRI—SSRIa | 84 |
| Other (frequency <5) | 3 |
| Cardiac arrhythmias | 27 |
| Potassium—spironolactone/amiloride | 19 |
| Verapamil/diltiazem—beta blockerb | 6 |
| Other (frequency <5) | 2 |
| Bleeding | 24 |
| Warfarin—ASA low dose | 14 |
| Warfarin—metronidazole/sulfamethoxazole | 6 |
| Other (frequency <5) | 4 |
| Sedation | 9 |
| Opioidc - phenobarbital | 5 |
| Other (frequency <5) | 4 |
| Immunosuppressant toxicity | 7 |
| Tacrolimus—itraconazole/posaconazole | 5 |
| Other (frequency <5) | 2 |
| Other adverse effect (frequency < 5) | 13 |
| Total adverse effect | 167 |
Potential clinical effects and summarized frequencies in bold. For each group interaction pairs with a frequency <5 are summarized as other. Groups of potential interactions with a frequency <5 are summarized as other. SSRI selective serotonin reuptake inhibitor, ASA acetylsalicylic acid.
a Sertraline, fluoxetine, paroxetine, escitalopram, citalopram.
b Metoprolol, propranolol, bisoprolol.
c Oxycodone, morphine, codeine.